Clinical Trial Update: Study of ACT-129968 in Adult Patients With Seasonal Allergic Rhinitis [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update for ACT-129968 in adults with seasonal allergic rhinitis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Seasonal Allergic Rhinitis

Drugs mentioned

• ACT-129968

Snippet

Sponsor: Idorsia Pharmaceuticals Ltd. | Conditions: Seasonal Allergic Rhinitis | Phase 2 | Status: COMPLETED